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Background
OX-2 is a member of the immunoglobulin supergene
family of receptors . sOX-2 was originally described as a
myeloid receptor, being expressed on macrophages,
granulocytes and dendritic cells, and also expressed on
T cells, Bcells, and natural killer cells. It displays a
restricted tissue distribution, including activated T and
B cells. sOX-2 is induced by inflammatory cytokines,
including TNF- and bindsto OX-2 receptor.We evalu-
ated other biomarkers like high-sensitivity CRP(hs-CRP)
in DFI patients to compare with that of healthy controls.
Possible correlationswere investigated between these
markers and creatinine levels, Wagner grading system
(WGS), and body mass index(BMI), as well as sedimen-
tation rate, preprandial glucose levels, and age.
Methods
We enrolled 23 healthy controls (group A) and 22
T2DM-DFI patients (group B). Group B patients had
diabetic nephropathy and foot disease. The T2DM-DFI
definition was infection, ulceration, or destruction of
deep tissues of the foot associated with neuropathy and/
or peripheral arterial disease in the lower extremity of
people with diabetes.
Results
The demographics of the analyzed patients are shown in
Table 1. Group B had the following values: DM period:
27.9±10.3 year [mean ±SD], HbA1c: 9.52±0.44% (normal
range: 4–6%) and WGS: 1.61 (5 patients with grade 1, 5
patients with grade 2, 7 patients with grade 3, and 5
patient with grade 4). The sOX-2 level in the patient
group was 173.8±3.1[mean ±SEM] and in the healthy
control group it was 70.52±1.2 [mean ±SEM].
[p<0.0001) (Figure 1). The HbA1c, BUN, creatinine, hs-
CRP levels, and sedimentation rates were higher in the
patient group (p<0.0001, p<0.001, p<0.001, p<0.005, and
p<0.0001, respectively). There was a positive correlation
between sOX-2 levels and BUN and creatinine rate
values (p<0.05), (r1=0.498; r2=0.675). There was a posi-
tive correlation between: HbA1c values and CRP, pre-
prandial glucose, postprandial glucose, and
sedimentation rate values (p<0.01, respectively r1 0.479;
r2: 0.549; r3: 0.486, r4: 0.858); and between hs-CRP
values and BMI values (p<0.05; r: 0.622). In subgroup
analysis of T2DM-DFI patients we noticed that sOX-2
levels were higher in WGS I and II patients than in
WGS III and IV patients.
Conclusions
All these results show that the levels of sOX-2 were
higher in macrovascular complication of DM as DFI
than in autoimmune diaseases and inflamatory skin dis-
orders. Thus, we suggest that there were vascular,
immunologic, and neurologic components in DFI
whereas autoimmune diaseases and inflamatory skin dis-
orders had only an immunologic component. This
should be the evidence of has sOX-2 major pro-inflam-
matory effect in vascular complication.
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